[{"address1": "18702 North Creek Parkway", "address2": "Suite 100", "city": "Bothell", "state": "WA", "zip": "98011", "country": "United States", "phone": "425 939 7410", "website": "https://immunome.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, including IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.", "fullTimeEmployees": 118, "companyOfficers": [{"maxAge": 1, "name": "Dr. Clay B. Siegall Ph.D.", "age": 63, "title": "Chairman, President & CEO", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 1235350, "exercisedValue": 0, "unexercisedValue": 15820780}, {"maxAge": 1, "name": "Ms. Sandra G. Stoneman Esq., J.D.", "age": 51, "title": "Chief Legal Officer, General Counsel & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 715350, "exercisedValue": 0, "unexercisedValue": 341880}, {"maxAge": 1, "name": "Mr. Kinney  Horn", "age": 49, "title": "Chief Business Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 598862, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Max  Rosett", "age": 34, "title": "Chief Financial Officer", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philip  Tsai", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack  Higgins Ph.D.", "age": 44, "title": "Chief Scientific Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 956342, "exercisedValue": 0, "unexercisedValue": 734891}, {"maxAge": 1, "name": "Dr. Robert J. Lechleider M.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 512488, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Roee  Shahar", "title": "Executive Vice President of Commercial", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 10, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.43, "open": 7.43, "dayLow": 7.275, "dayHigh": 7.85, "regularMarketPreviousClose": 7.43, "regularMarketOpen": 7.43, "regularMarketDayLow": 7.275, "regularMarketDayHigh": 7.85, "payoutRatio": 0.0, "beta": 2.012, "forwardPE": -2.6793103, "volume": 308161, "regularMarketVolume": 308161, "averageVolume": 1124298, "averageVolume10days": 1074460, "averageDailyVolume10Day": 1074460, "bid": 7.72, "ask": 7.81, "bidSize": 1, "askSize": 1, "marketCap": 676081664, "fiftyTwoWeekLow": 5.15, "fiftyTwoWeekHigh": 16.81, "priceToSalesTrailing12Months": 74.779526, "fiftyDayAverage": 7.9771, "twoHundredDayAverage": 11.36005, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 433572352, "profitMargins": 0.0, "floatShares": 69448358, "sharesOutstanding": 87011800, "sharesShort": 12481987, "sharesShortPriorMonth": 9523078, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.1436, "heldPercentInsiders": 0.15467, "heldPercentInstitutions": 0.60333997, "shortRatio": 8.07, "shortPercentOfFloat": 0.1499, "impliedSharesOutstanding": 87011800, "bookValue": 2.81, "priceToBook": 2.7651246, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -292963008, "trailingEps": -5.0, "forwardEps": -2.9, "enterpriseToRevenue": 47.956, "enterpriseToEbitda": -2.855, "52WeekChange": -0.52002585, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 7.77, "targetHighPrice": 38.0, "targetLowPrice": 20.0, "targetMeanPrice": 26.0, "targetMedianPrice": 24.0, "recommendationMean": 1.22222, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 217303008, "totalCashPerShare": 2.499, "ebitda": -151888992, "totalDebt": 4832000, "quickRatio": 4.001, "currentRatio": 4.076, "totalRevenue": 9041000, "debtToEquity": 2.667, "revenuePerShare": 0.154, "returnOnAssets": -0.49339, "returnOnEquity": -1.94629, "grossProfits": -120501000, "freeCashflow": -96318000, "operatingCashflow": -110794000, "revenueGrowth": -0.284, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -20.306059, "financialCurrency": "USD", "symbol": "IMNM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1746724523, "exchange": "NCM", "messageBoardId": "finmb_108518404", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1601645400000, "regularMarketChange": 0.34000015, "regularMarketDayRange": "7.275 - 7.85", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1124298, "fiftyTwoWeekLowChange": 2.62, "fiftyTwoWeekLowChangePercent": 0.50873786, "fiftyTwoWeekRange": "5.15 - 16.81", "fiftyTwoWeekHighChange": -9.039999, "fiftyTwoWeekHighChangePercent": -0.5377751, "fiftyTwoWeekChangePercent": -52.002586, "earningsTimestamp": 1742414700, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -5.0, "epsForward": -2.9, "epsCurrentYear": -2.296, "priceEpsCurrentYear": -3.3841462, "fiftyDayAverageChange": -0.20709991, "fiftyDayAverageChangePercent": -0.025961805, "twoHundredDayAverageChange": -3.5900502, "twoHundredDayAverageChangePercent": -0.31602415, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-02", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "marketState": "REGULAR", "regularMarketChangePercent": 4.579127, "regularMarketPrice": 7.77, "shortName": "Immunome, Inc.", "longName": "Immunome, Inc.", "displayName": "Immunome", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]